| Dr Vara Kantipong, MD | |
|
3105 W 15th St, Suite C, Plano, TX 75075-7700 | |
| (972) 867-7915 | |
| (972) 964-0237 |
| Full Name | Dr Vara Kantipong |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 3105 W 15th St, Plano, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730131871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | E6820 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vara Kantipong, MD 3105 W 15th St, Suite C, Plano, TX 75075-7700 Ph: (972) 867-7915 | Dr Vara Kantipong, MD 3105 W 15th St, Suite C, Plano, TX 75075-7700 Ph: (972) 867-7915 |
News Archive
Childbirth is not a major contributor to sexual dysfunction in women later in life, according to a new study led by UC San Francisco researchers.
Macro International (ICF Macro), a subsidiary of ICF International (NASDAQ:ICFI), was awarded two re-compete, indefinite delivery/indefinite quantity (ID/IQ) contracts valued at more than $20 million with the U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Mental Health Services.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.
Janssen Research & Development, LLC ("Janssen") today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA™ (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its collaboration partner Pharmacyclics, Inc.
› Verified 2 days ago
Gregg M Santilli, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3600 Communications Pkwy, Suite 675, Plano, TX 75093 Phone: 972-473-7544 Fax: 972-473-7545 | |
Dr. Eric Kavosh, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5904 Chapel Hill Blvd Ste 103, Plano, TX 75093 Phone: 972-473-2532 Fax: 972-473-2535 | |
Mary D Blomquist, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 6100 Windcom Ct, Suite 101, Plano, TX 75093 Phone: 972-398-3500 Fax: 972-398-3512 | |
Eric John Schmitt, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 3300 Dallas Pkwy, Ste 224, Plano, TX 75093 Phone: 972-528-4811 Fax: 855-828-0878 | |
Leslie A Weisberg, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6300 W Parker Rd, Ste 220, Plano, TX 75093 Phone: 972-981-8215 Fax: 972-981-3099 | |
Richard F Herrscher, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3600 Communications Pkwy, Suite 675, Plano, TX 75093 Phone: 972-473-7544 Fax: 972-473-7545 |